1. Indonesia Stocks

  2. •

    Health technology

  3. •

    Medical specialties
PT Jayamas Medica Industri Tbk

PT Jayamas Medica Industri Tbk

IIDX:OMED
198.00
IDR
-2.00
(-1.00%)
15.40EPS
13.47P/E
5.56TMarket Cap
Nov 03Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
45.38
73.71
82.29
64.27
64.19
69.69
76.32
83.27
Basic EPS, GAAP
8.36
25.33
20.8
10.56
9.59
11.89
13.57
15.29
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
9.42
9.24
3.17
2.88
3.57
- -
Book Value per Share
20.75
34.7
45.25
75.55
81.98
90.96
100.73
104.76
Tangible Book Value per Share
20.75
34.65
45.22
74.52
80.97
90.09
99.86
103.91
Basic Weighted Avg Shares
27,059
27,059
27,059
27,059
27,059
27,059
27,041
27,024
Sales/Revenue/Turnover
1,228,049
1,994,540
2,226,573
1,739,054
1,736,990
1,885,822
2,063,817
2,250,247
Operating Margin (%)
23.79
42.51
32.91
21.4
17.28
18.32
18.88
19.98
Depreciation Expense
385
3,210
17,288
22,939
25,810
19,987
22,349
23,917
Net Income, GAAP
226,208
685,510
562,692
285,782
259,360
321,673
366,949
413,149
Effective Tax Rate (%)
24.57
19.43
21.78
21.93
19.81
17.78
18.9
19.54
Profit Margin (%)
18.42
34.37
25.27
16.43
14.93
17.06
17.78
18.36
Working Capital
491,928
1,003,355
1,217,541
1,881,901
1,911,133
1,965,859
2,201,714
2,230,104
LT Debt
675
162,334
171,537
178,453
175,607
13,683
184,253
212,279
Total Equity
565,801
950,567
1,245,442
2,069,420
2,245,408
2,495,689
2,752,770
2,865,556
Return on Invested Capital (%)
- -
78.61
42.99
15.67
10.27
11.16
11.14
11.57
Return on Capital (%)
- -
81.4
44.9
16.06
11.62
13.12
13.41
14.45
Return on Common Equity (%)
- -
91.38
52.02
17.49
12.17
13.75
14.16
15.41

Capital Structure

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
31,857
49,987
50,365
LT Borrowings
184,253
183,424
182,624
LT Finance Leases
- -
34,103
29,654
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
27,008
27,008
27,008
Market Capitalization
5,563,673
6,968,095
5,563,673

Working Capital

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,437,034
2,497,787
2,535,880
Cash, Cash Equivalents & STI
1,343,326
1,367,327
1,418,282
Accounts Receivable, Net
279,006
297,947
324,045
Inventories
746,435
758,277
735,800
Total Current Liabilities
235,320
225,426
305,776
Payables & Accruals
- -
- -
- -
ST Debt
31,857
49,987
50,365
Deferred Revenue
- -
- -
- -

Growth Rates

IDR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
25.43%
10.3%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
-7.66%
14.07%
Sales/Revenue/Turnover
- -
1.52%
9.44%
Total Cash Common Dividend
- -
- -
23.9%

Quarterly Revenue

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
427,388
452,260
484,847
521,327
1,885,822
2025
436,315
489,531
- -
593,923
2,063,817
2026
572,248
594,545
- -
- -
- -

Quarterly Earnings Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.35
2.97
2.48
4.09
11.89
2025
2.69
2.99
- -
4.17
13.57
2026
3.64
4.48
- -
- -
- -

Quarterly Dividends Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
2.88
2025
- -
- -
- -
- -
3.57
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Herlien Sri Ariani
Full Time Employees
1,198
Sector
Health technology
Industry
Medical specialties
Address
Jl. Bypass Krian RT 05/RW 01 Sidoarjo JI Indonesia 61262
IPO Date
Nov 8, 2022
Website
onemed.co.id
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
PT Jayamas Medica Industri Tbk is an Indonesian company primarily engaged in the manufacturing and distribution of medical and healthcare products. Its core products include disposable medical devices such as bed pads, diapers, adult incontinence products, feminine hygiene products, and other healthcare disposables. The company serves hospitals, healthcare institutions, and consumers primarily in Indonesia and the Southeast Asian region. Founded in 1985, PT Jayamas Medica Industri Tbk is headquartered in Jakarta, Indonesia. The company operates within the healthcare and medical supplies industry, focusing on hygienic and disposable solutions that support patient care and personal health management. It offers a range of branded products targeting different segments such as adult care, baby care, and feminine care, aligning with growing demand for quality medical disposables in the region. Recent company developments include strategic business expansions aiming to increase production capacity and product offerings to meet market demand in Indonesia and beyond. PT Jayamas Medica Industri Tbk has pursued enhancements in manufacturing efficiency and has explored partnerships to strengthen its distribution network. However, no major rebranding or acquisitions have been reported in the last two years, with the company maintaining its established market presence through continuous product innovation and operational improvements. The company remains publicly listed on the Indonesia Stock Exchange under the ticker OMED.JK and continues to invest in research and development to advance its product portfolio while expanding its footprint in Southeast Asia. PT Jayamas Medica Industri Tbk’s focused approach on disposable medical and healthcare products positions it as a key player in Indonesia's healthcare supply chain.